Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Sleep Medicine · Narcolepsy Type 1

Prioritizing Your Long-Term Health

At a Glance

Narcolepsy Type 1 affects more than alertness: it is linked with weight gain, high blood pressure, blood sugar problems, mood symptoms, attention difficulties, and sleep apnea. Regular checks of weight, blood pressure, A1c, cholesterol, and mental health support safer long-term care.

Managing Narcolepsy Type 1 (NT1) is a long-term commitment that extends beyond staying awake. Because the loss of orexin in the brain affects systems that regulate metabolism, heart rate, and mood, people living with NT1 face a higher risk for certain health conditions over time [1][2]. Staying healthy involves individualized monitoring and a “whole-person” approach to care.

Metabolic and Heart Health

The loss of orexin in the brain may alter how your body regulates energy and weight. As a result, cardiometabolic issues are commonly seen alongside NT1, though factors like obesity, sleep apnea, and treatments also play a major role.

  • Weight Management: Many people with NT1 struggle with obesity or sudden weight gain, often beginning early in the course of the disease [1][3].
  • Diabetes and Blood Sugar: Rates of prediabetes and Type 2 diabetes are higher in the NT1 population compared to those without narcolepsy [1][2].
  • Blood Pressure and Cholesterol: Hypertension (high blood pressure) and dyslipidemia (unhealthy cholesterol levels) are frequent [1]. Additionally, some people with NT1 experience “non-dipping” blood pressure, meaning their blood pressure does not safely drop at night, which can strain the heart [4].

How Medications Affect Your Risk

The medications used to treat NT1 can interact with your cardiovascular health in different ways. Work with your doctor to choose the safest options for your profile.

  • Stimulants and Wake-Promoters: Drugs like methylphenidate, amphetamines, and solriamfetol can increase your heart rate and blood pressure [5][6]. Regular blood pressure monitoring is recommended while taking these [7].
  • Oxybate and Sodium: Standard sodium oxybate contains a high amount of sodium, which may be a concern for those with existing heart issues [8]. Low-sodium oxybate offers a significant reduction in sodium and may be a better choice for maintaining healthy blood pressure, though it carries the same neurological risks [9].
  • Weight Changes: Medication effects on weight vary widely. Some wake-promoting agents may suppress appetite, while other treatments might influence weight differently [10][11].

Mental Health and Cognition

NT1 also profoundly impacts your emotional well-being and how you process information.

  • Depression and Anxiety: These are the most common psychiatric comorbidities in NT1 [12].
  • Suicide Risk: Suicidal thoughts can occur and require immediate professional attention. If you experience thoughts of self-harm, please reach out to an emergency service or a national crisis line immediately. While effective narcolepsy treatment may improve overall mood and reduce these thoughts, it does not guarantee protection against depression or suicidality [12].
  • ADHD and Attention: A significant number of people with NT1 also experience symptoms of ADHD, particularly the inattentive type [13]. You may find that even when you aren’t feeling sleepy, it is still difficult to maintain focus or organize tasks [14].

Your Long-Term Care Plan

Because NT1 impacts so many systems, your “care team” should ideally include more than just a sleep specialist.

  1. Individualized Screenings: Discuss a schedule with your doctor for checking your blood pressure, weight, blood sugar (A1c), and cholesterol. The frequency should be based on your age, BMI, family history, and the medications you take [7][15].
  2. Mental Health Check-ins: Screenings for depression and anxiety should be a routine part of your follow-up visits [12].
  3. Sleep Apnea Monitoring: Many people with NT1 also develop Obstructive Sleep Apnea (OSA), which can make narcolepsy symptoms worse if left untreated [16].
  4. Multidisciplinary Approach: Depending on your health, your team might include a primary care doctor, a cardiologist, and a therapist or psychiatrist to help manage the full range of NT1’s long-term effects [7][17].

Common questions in this guide

What long-term health problems are linked with Narcolepsy Type 1?
People with NT1 commonly need monitoring for weight gain or obesity, prediabetes or type 2 diabetes, high blood pressure, and unhealthy cholesterol levels. Some also have blood pressure that does not fall normally during sleep, which can place extra strain on the heart. Sleep apnea and mental health conditions may add to the overall health burden.
Can narcolepsy medications affect my heart or blood pressure?
Yes. Stimulants and wake-promoting medicines such as methylphenidate, amphetamines, and solriamfetol can raise heart rate or blood pressure, so monitoring may be needed. Standard sodium oxybate also contains substantial sodium, while low-sodium oxybate reduces sodium exposure but has the same neurological risks; your clinician can help weigh the options.
How often should I check blood pressure, A1c, and cholesterol with NT1?
There is no single schedule for everyone with NT1. Your clinician can set intervals based on your age, body mass index, family history, and medicines, and may monitor weight, blood pressure, A1c, which is a long-term blood sugar test, and cholesterol.
Does Narcolepsy Type 1 increase the risk of depression or anxiety?
Depression and anxiety are common mental health conditions in NT1, and some people also experience attention problems or ADHD symptoms. Suicidal thoughts need immediate professional attention, so contact emergency services or a crisis line right away if you may harm yourself. Narcolepsy treatment may improve mood but does not eliminate the risk.
Should people with NT1 be evaluated for sleep apnea?
Yes. Obstructive sleep apnea can occur alongside NT1 and may make narcolepsy symptoms worse when it is untreated. Your care team can decide whether sleep apnea monitoring or evaluation is appropriate for you.
Which doctors should be involved in long-term NT1 care?
Long-term care may include a sleep specialist and a primary care doctor, with a cardiologist for cardiovascular concerns and a therapist or psychiatrist for mental health support. The team can coordinate screening, medication decisions, and follow-up based on your health needs.
Can a severity scale help track my narcolepsy treatment?
A tool such as the Narcolepsy Severity Scale may help you and your clinician track how symptoms change over time. It should complement, rather than replace, discussion of sleepiness, attention, mood, medication effects, and overall health.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is my current cardiovascular risk score, and how do my narcolepsy medications impact that risk?
  2. 2.Since I may be at a higher risk for high blood pressure and prediabetes, how often should we be screening my blood pressure, A1c, and cholesterol?
  3. 3.Can we use a tool like the Narcolepsy Severity Scale to track my progress and see if my current treatment is effectively managing all my symptoms?
  4. 4.If I experience new symptoms of anxiety or low mood, who on my care team should I contact first, and how will we adjust my medications?
  5. 5.Would it be beneficial for me to see a primary care doctor or cardiologist to proactively manage the metabolic risks associated with my condition?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (17)
  1. 1

    Narcolepsy and metabolic disease: A meta-analytic synthesis.

    Zhang X, Yin W, Ren J, et al.

    Sleep medicine reviews 2026; (87()):102264 doi:10.1016/j.smrv.2026.102264.

    PMID: 41747645
  2. 2

    Narcolepsy Is Associated With Subclinical Cardiovascular Disease as Early as Childhood: A Big Data Analysis.

    Kaufmann CN, Riaz M, Park H, et al.

    Journal of the American Heart Association 2025; (14(12)):e039899 doi:10.1161/JAHA.124.039899.

    PMID: 40207482
  3. 3

    The role of mtDNA haplogroups on metabolic features in narcolepsy type 1.

    Caporali L, Moresco M, Pizza F, et al.

    Mitochondrion 2022; (63()):37-42 doi:10.1016/j.mito.2022.01.005.

    PMID: 35051655
  4. 4

    Cardiovascular disorders in narcolepsy: Review of associations and determinants.

    Jennum PJ, Plazzi G, Silvani A, et al.

    Sleep medicine reviews 2021; (58()):101440 doi:10.1016/j.smrv.2021.101440.

    PMID: 33582582
  5. 5

    Rising pressure to understand the risks of hypertension in children with narcolepsy type 1.

    Montesano E, Garcia ME, Lyon S, et al.

    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2025; (21(6)):1081-1091 doi:10.5664/jcsm.11628.

    PMID: 40103309
  6. 6

    A randomized study of solriamfetol for excessive sleepiness in narcolepsy.

    Thorpy MJ, Shapiro C, Mayer G, et al.

    Annals of neurology 2019; (85(3)):359-370 doi:10.1002/ana.25423.

    PMID: 30694576
  7. 7

    Cardiovascular Risks in People With Narcolepsy: Expert Panel Consensus Recommendations.

    Kwon Y, Gami AS, Javaheri S, et al.

    Journal of the American Heart Association 2024; (13(16)):e035168 doi:10.1161/JAHA.124.035168.

    PMID: 39119988
  8. 8

    The sodium in sodium oxybate: is there cause for concern?

    Avidan AY, Kushida CA

    Sleep medicine 2020; (75()):497-501 doi:10.1016/j.sleep.2020.09.017.

    PMID: 33022487
  9. 9

    Calcium, magnesium, potassium, and sodium oxybates oral solution for cataplexy or excessive daytime sleepiness associated with narcolepsy.

    Abad VC

    Expert opinion on pharmacotherapy 2023; (24(8)):875-885 doi:10.1080/14656566.2023.2204187.

    PMID: 37060579
  10. 10

    Decreased body mass index during treatment with sodium oxybate in narcolepsy type 1.

    Schinkelshoek MS, Smolders IM, Donjacour CE, et al.

    Journal of sleep research 2019; (28(3)):e12684 doi:10.1111/jsr.12684.

    PMID: 29504180
  11. 11

    Weight changes during treatment with low-sodium oxybate in two phase 3 clinical studies in participants with narcolepsy or idiopathic hypersomnia.

    Foldvary-Schaefer N, Skowronski R, Chandler P, et al.

    Sleep medicine 2025; (133()):106602 doi:10.1016/j.sleep.2025.106602.

    PMID: 40570742
  12. 12

    Depression and suicidal thoughts in untreated and treated narcolepsy: Systematic analysis.

    Barateau L, Lopez R, Chenini S, et al.

    Neurology 2020; (95(20)):e2755-e2768 doi:10.1212/WNL.0000000000010737.

    PMID: 32963102
  13. 13

    ADHD in narcolepsy: A closer look at prevalence and ties.

    Ren J, Zhao X, Su C, et al.

    Neuroscience and biobehavioral reviews 2024; (156()):105471 doi:10.1016/j.neubiorev.2023.105471.

    PMID: 38030099
  14. 14

    The nature and magnitude of cognitive impairment in narcolepsy type 1, narcolepsy type 2, and idiopathic hypersomnia: a meta-analysis.

    Harel BT, Gattuso JJ, Latzman RD, et al.

    Sleep advances : a journal of the Sleep Research Society 2024; (5(1)):zpae043 doi:10.1093/sleepadvances/zpae043.

    PMID: 39036743
  15. 15

    Effect of psychostimulants on blood pressure profile and endothelial function in narcolepsy.

    Bosco A, Lopez R, Barateau L, et al.

    Neurology 2018; (90(6)):e479-e491 doi:10.1212/WNL.0000000000004911.

    PMID: 29321233
  16. 16

    Comorbidity of obstructive sleep apnea and narcolepsy: A challenging diagnosis and complex management.

    Miano S, Kheirandish-Gozal L, De Pieri M

    Sleep medicine: X 2024; (8()):100126 doi:10.1016/j.sleepx.2024.100126.

    PMID: 39386319
  17. 17

    Narcolepsy and psychiatric comorbidity: a review of the literature.

    Verstraete L, Van Den Bossche M

    International journal of clinical and health psychology : IJCHP 2025; (25(2)):100591 doi:10.1016/j.ijchp.2025.100591.

    PMID: 40546276

This page discusses long-term health monitoring for people with Narcolepsy Type 1 for informational purposes only and does not constitute medical advice. Your sleep specialist and primary care clinician should tailor screenings, medication choices, and mental health support to your needs.

Get notified when new evidence is published on narcolepsy 1.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.